tradingkey.logo
搜索

Phathom Pharmaceuticals Inc

PHAT
添加自选
10.610USD
-0.250-2.30%
收盘 06/24, 16:00美东报价延迟15分钟
846.21M总市值
亏损市盈率 TTM

股东统计

更新时间: 5月10日 周日
更新时间: 5月10日 周日
持股股东
股东类型
持股股东
持股股东
占比
Frazier Life Sciences Management, L.P.
15.63%
Medicxi Ventures (UK) LLP
9.36%
Millennium Management LLC
5.24%
Abingworth Management Limited
4.38%
Invesco Advisers, Inc.
3.99%
其他
61.39%
持股股东
持股股东
占比
Frazier Life Sciences Management, L.P.
15.63%
Medicxi Ventures (UK) LLP
9.36%
Millennium Management LLC
5.24%
Abingworth Management Limited
4.38%
Invesco Advisers, Inc.
3.99%
其他
61.39%
股东类型
持股股东
占比
Investment Advisor
22.16%
Venture Capital
19.25%
Private Equity
16.16%
Investment Advisor/Hedge Fund
12.43%
Hedge Fund
11.55%
Individual Investor
4.60%
Research Firm
1.65%
Bank and Trust
0.26%
Pension Fund
0.10%
其他
11.83%

机构持股

更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
354
69.84M
87.57%
-14.23M
2025Q4
328
60.04M
77.11%
-25.29M
2025Q3
315
60.57M
85.19%
-24.26M
2025Q2
318
61.93M
88.60%
-20.64M
2025Q1
321
68.36M
98.42%
-14.76M
2024Q4
311
70.95M
103.79%
-11.79M
2024Q3
293
76.11M
113.29%
+9.50M
2024Q2
284
61.82M
105.14%
-1.53M
2024Q1
280
58.85M
100.56%
-3.74M
2023Q4
274
57.52M
100.58%
-4.32M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Frazier Life Sciences Management, L.P.
12.47M
15.82%
+276.03K
+2.26%
Dec 31, 2025
Medicxi Ventures (UK) LLP
7.46M
9.47%
--
--
Dec 31, 2025
Millennium Management LLC
4.18M
5.3%
+2.10M
+100.67%
Mar 06, 2026
Abingworth Management Limited
3.50M
4.44%
--
--
Dec 31, 2025
Invesco Advisers, Inc.
3.19M
4.04%
-45.33K
-1.40%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
3.14M
3.99%
+86.29K
+2.82%
Dec 31, 2025
Ensign Peak Advisors, Inc.
2.35M
2.98%
-151.32K
-6.04%
Dec 31, 2025
New Enterprise Associates (NEA)
1.96M
2.49%
--
--
Dec 31, 2025
683 Capital Management LLC
1.78M
2.27%
-35.38K
-1.94%
Dec 31, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Simplify Propel Opportunities ETF
6.45%
Virtus LifeSci Biotech Products ETF
2.16%
State Street SPDR S&P Pharmaceuticals ETF
1.37%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.35%
Invesco Dorsey Wright Healthcare Momentum ETF
0.92%
Invesco Dorsey Wright SmallCap Momentum ETF
0.53%
iShares U.S. Pharmaceuticals ETF
0.23%
ProShares Ultra Nasdaq Biotechnology
0.13%
iShares Micro-Cap ETF
0.11%
Invesco Nasdaq Biotechnology ETF
0.1%
查看更多
Simplify Propel Opportunities ETF
占比6.45%
Virtus LifeSci Biotech Products ETF
占比2.16%
State Street SPDR S&P Pharmaceuticals ETF
占比1.37%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
占比1.35%
Invesco Dorsey Wright Healthcare Momentum ETF
占比0.92%
Invesco Dorsey Wright SmallCap Momentum ETF
占比0.53%
iShares U.S. Pharmaceuticals ETF
占比0.23%
ProShares Ultra Nasdaq Biotechnology
占比0.13%
iShares Micro-Cap ETF
占比0.11%
Invesco Nasdaq Biotechnology ETF
占比0.1%
KeyAI